DOI: 10.1055/s-00000030

Der Klinikarzt


Janni W, Rack BK, Gluz O. et al.
Pooled analysis of two randomized phase III trials (PlanB/SuccessC) comparing six cycles of docetaxel and cyclophosphamide to sequential anthracycline taxane chemotherapy in patients with intermediate and high risk HER2-negative early breast cancer (n=5,923).
J Clin Oncol. 2018
36. (suppl; abstr 522)

Download Bibliographical Data

Search in: